| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |